Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Davood Khalili, Ph.D.

Title
Institution
Department
Address

Biography
Leiden University Medical Center, Leiden, The NetherlandsVisiting Scholar2017Medical Statistics
Shahid Beheshti University of Medical Sciences, Tehran, IranPhD2012Epidemiology
Erasmus MC University, Rotterdam, The Netherlands2011Epidemiology and Biostatistics
Shahid Beheshti University of Medical Sciences, Tehran, IranMPH2008Public Health
Urmia University of Medical Sciences, Urmia, IranMD1998Medicine
2017
Honor researcher
2015
Excellent Scientist
2012
Honor researcher
2009
Honor PhD student
2008
Honor PhD student

Overview
Davood Khalili is a faculty member in the Research Institute for Endocrine Sciences, Tehran, Iran (http://endocrine.ac.ir). He is working on cardiometabolic disorders in the framework of large population-based cohort studies and clinical/community/field trials. Clinical prediction models and medical decision making are his main interests with focus on the clinical usefulness of prediction models. He is the head of the Department of Biostatistics and Epidemiology in the institute. He is also a board member of the Scientific Association for Public Health in Iran (SAPHIR, http://saphirnetwork.org) and the scientific secretariat of the Iran Cohort Consortium (ICC, http://irancohorts.ir).
He has joined the Department of Global Health and Population as a Lown Scholar in 2017.

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Rasooli R, Ramezankhani A, Khalili D, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study. Ann Med. 2022 Dec; 54(1):3258-3268. PMID: 36382719; PMCID: PMC9673780.
    Citations:    Fields:    Translation:Humans
  2. Koohi F, Ahmadi N, Azizi F, Khalili D, Valizadeh M. Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study. J Transl Med. 2022 Nov 08; 20(1):518. PMID: 36348481; PMCID: PMC9644604.
    Citations:    Fields:    Translation:Humans
  3. Mehran L, Mousapour P, Khalili D, Cheraghi L, Honarvar M, Amouzegar A, Azizi F. BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS). Sci Rep. 2022 Nov 01; 12(1):18370. PMID: 36319811; PMCID: PMC9626493.
    Citations:    Fields:    Translation:Humans
  4. Asgari S, Masrouri S, Khalili D, Azizi F, Hadaegh F. Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study. Front Cardiovasc Med. 2022; 9:1018403. PMID: 36386371; PMCID: PMC9662168.
    Citations:    
  5. Moradi M, Kabir A, Khalili D, Lakeh MM, Dodaran MS, Pazouki A, Kermansaravi M, Alibeigi P, Moazenzadeh H, Abdolhosseini MR, Eghbali F, Baradaran HR. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study. BMC Endocr Disord. 2022 Oct 26; 22(1):260. PMID: 36289529; PMCID: PMC9598002.
    Citations:    Fields:    Translation:Humans
  6. Sadeghi S, Mahani F, Amiri P, Alamdari S, Khalili D, Saadat N, Ebadi SA, Mahdavi Hazaveh AR, Shahrzad MK, Azizi F. Barriers Toward the National Program for Prevention and Control of Diabetes in Iran: A Qualitative Exploration. Int J Health Policy Manag. 2022 Oct 18. PMID: 36300256.
    Citations:    Fields:    
  7. Alizadeh Z, Baradaran HR, Kohansal K, Hadaegh F, Azizi F, Khalili D. Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same? Front Endocrinol (Lausanne). 2022; 13:1041808. PMID: 36277718; PMCID: PMC9585180.
    Citations:    Fields:    Translation:Humans
  8. Jahromi MK, Ebadinejad A, Barzin M, Mahdavi M, Niroomand M, Khalili D, Valizadeh M, Azizi F, Hosseinpanah F. Association of cumulative excess weight and waist circumference exposure with transition from metabolically healthy obesity to metabolically unhealthy. Nutr Metab Cardiovasc Dis. 2022 11; 32(11):2544-2552. PMID: 36163212.
    Citations:    Fields:    Translation:Humans
  9. Ramezani Tehrani F, Behboudi-Gandevani S, Farzadfar F, Hosseinpanah F, Hadaegh F, Khalili D, Soleymani-Dodaran M, Valizadeh M, Abedini M, Rahmati M, Bidhendi Yarandi R, Torkestani F, Abdollahi Z, Bakhshandeh M, Zokaee M, Amiri M, Bidarpour F, Javanbakht M, Nabipour I, Nasli Esfahani E, Ostovar A, Azizi F. A Cluster Randomized Noninferiority Field Trial of Gestational Diabetes Mellitus Screening. J Clin Endocrinol Metab. 2022 06 16; 107(7):e2906-e2920. PMID: 35325164.
    Citations:    Fields:    Translation:Humans
  10. Koohi F, Kohansal K, Naz MSG, Derakhshan S, Azizi F, Khalili D. The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999-2018. BMC Public Health. 2022 03 28; 22(1):596. PMID: 35346132; PMCID: PMC8961927.
    Citations:    Fields:    Translation:Humans
  11. Hosseinpour-Niazi S, Mirmiran P, Hadaegh F, Mahdavi M, Khalili D, Daneshpour MS, Momenan AA, Azizi F. Improvement of glycemic indices by a hypocaloric legume-based DASH diet in adults with type 2 diabetes: a randomized controlled trial. Eur J Nutr. 2022 Sep; 61(6):3037-3049. PMID: 35347394.
    Citations:    Fields:    
  12. Sharifi H, Jahani Y, Mirzazadeh A, Ahmadi Gohari M, Nakhaeizadeh M, Shokoohi M, Eybpoosh S, Tohidinik HR, Mostafavi E, Khalili D, Hashemi Nazari SS, Karamouzian M, Haghdoost AA. Estimating COVID-19-Related Infections, Deaths, and Hospitalizations in Iran Under Different Physical Distancing and Isolation Scenarios. Int J Health Policy Manag. 2022 Mar 01; 11(3):334-343. PMID: 32772007; PMCID: PMC9278464.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  13. Sadeghi S, Khalili D, Ramezankhani A, Mansournia MA, Parsaeian M. Diabetes mellitus risk prediction in the presence of class imbalance using flexible machine learning methods. BMC Med Inform Decis Mak. 2022 02 10; 22(1):36. PMID: 35139846; PMCID: PMC8830137.
    Citations: 1     Fields:    Translation:Humans
  14. Fahimfar N, Fotouhi A, Mansournia MA, Malekzadeh R, Sarrafzadegan N, Azizi F, Mansourian M, Sepanlou SG, Emamian MH, Hadaegh F, Roohafza H, Hashemi H, Poustchi H, Pourshams A, Samavat T, Sharafkhah M, Talaei M, Van Klaveren D, Steyerberg EW, Khalili D. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. Int J Health Policy Manag. 2022 Feb 01; 11(2):210-217. PMID: 32668896; PMCID: PMC9278599.
    Citations: 1     Fields:    Translation:Humans
  15. Fahimfar N, Malekzadeh R, Fotouhi A, Mansournia MA, Sarrafzadegan N, Azizi F, Sepanlou SG, Mansourian M, Hadaegh F, Emamian MH, Poustchi H, Talaei M, Pourshams A, Roohafza H, Sharafkhah M, Samavat T, Lotfaliany M, Steyerberg EW, Khalili D. An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country. J Clin Epidemiol. 2022 06; 146:1-11. PMID: 34920114.
    Citations:    Fields:    Translation:Humans
  16. Asgari S, Khalili D, Mehrabi Y, Hadaegh F. Letter to the Editor Regarding "Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study". Diabetes Ther. 2022 Jan; 13(1):217-219. PMID: 34860331; PMCID: PMC8776919.
    Citations:    
  17. Rezaianzadeh A, Morasae EK, Khalili D, Seif M, Bahramali E, Azizi F, Bagheri P. Predicting the natural history of metabolic syndrome with a Markov-system dynamic model: a novel approach. BMC Med Res Methodol. 2021 11 27; 21(1):260. PMID: 34837958; PMCID: PMC8627615.
    Citations:    Fields:    Translation:Humans
  18. Kabootari M, Habibi Tirtashi R, Hasheminia M, Bozorgmanesh M, Khalili D, Akbari H, Roshandel G, Hadaegh F. Clinical features, risk factors and a prediction model for in-hospital mortality among diabetic patients infected with COVID-19: data from a referral centre in Iran. Public Health. 2022 Jan; 202:84-92. PMID: 34933204; PMCID: PMC8595350.
    Citations:    Fields:    Translation:Humans
  19. Koohi F, Amiri P, Mehrabi Y, Karimi M, Khalili D. Development and validation of a knowledge, attitude, and practice questionnaire regarding cardiovascular diseases in an Iranian general population. BMC Public Health. 2021 11 09; 21(1):2050. PMID: 34753475.
    Citations:    Fields:    Translation:Humans
  20. Khalili D, Hadaegh F, Pirzadeh M, Azizi F. Polypill's cardiovascular and non-cardiovascular mortalities. J Diabetes Metab Disord. 2021 Dec; 20(2):2133-2134. PMID: 34900849; PMCID: PMC8630303.
    Citations:    
  21. Lak A, Maher A, Zali A, Badr S, Mostafavi E, Baradaran HR, Hanani K, Toomanian A, Khalili D. A description of spatial-temporal patterns of the novel COVID-19 outbreak in the neighbourhoods' scale in Tehran, Iran. Med J Islam Repub Iran. 2021; 35:128. PMID: 35321381; PMCID: PMC8840845.
    Citations: 2     
  22. Khalili D, Varzandeh M. Triaging diabetes research in perplexed COVID-19 resources: Avoiding research waste through a corpus-based approach. J Res Med Sci. 2021; 26:83. PMID: 34760000.
    Citations:    
  23. Khodamoradi F, Nazemipour M, Mansournia N, Yazdani K, Khalili D, Mansournia MA. The Effects of Smoking on Metabolic Syndrome and Its Components Using Causal Methods in the Iranian Population. Int J Prev Med. 2021; 12:118. PMID: 34760129; PMCID: PMC8551769.
    Citations:    
  24. Jalali-Farahani S, Amiri P, Fakhredin H, Torshizi K, Cheraghi L, Khalili D, Azizi F. Health-related quality of life in men and women who experienced cardiovascular diseases: Tehran Lipid and Glucose Study. Health Qual Life Outcomes. 2021 Sep 26; 19(1):225. PMID: 34565411.
    Citations:    Fields:    Translation:Humans
  25. Dehghani M, Davoodi Z, Bidari F, Moghaddam AM, Khalili D, Bahrami-Motlagh H, Jamali E, Alamdari S, Hosseinpanah F, Hedayati M, Valizadeh M. Association of different pathologic subtypes of growth hormone producing pituitary adenoma and remission in acromegaly patients: a retrospective cohort study. BMC Endocr Disord. 2021 Sep 16; 21(1):186. PMID: 34530798; PMCID: PMC8447747.
    Citations:    Fields:    Translation:Humans
  26. Sardarinia M, Asgari S, Hizomi Arani R, Eskandari F, Azizi F, Khalili D, Hadaegh F. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study. J Diabetes Investig. 2022 Feb; 13(2):317-327. PMID: 34403198; PMCID: PMC8847124.
    Citations: 1     Fields:    Translation:Humans
  27. Hosseini-Esfahani F, Alafchi B, Cheraghi Z, Doosti-Irani A, Mirmiran P, Khalili D, Azizi F. Using Machine Learning Techniques to Predict Factors Contributing to the Incidence of Metabolic Syndrome in Tehran: Cohort Study. JMIR Public Health Surveill. 2021 09 02; 7(9):e27304. PMID: 34473070; PMCID: PMC8446845.
    Citations:    Translation:Humans
  28. Asgari S, Khalili D, Zayeri F, Azizi F, Hadaegh F. Dynamic prediction models improved the risk classification of type 2 diabetes compared with classical static models. J Clin Epidemiol. 2021 12; 140:33-43. PMID: 34455032.
    Citations:    Fields:    Translation:Humans
  29. Cheraghi L, Amiri P, Vahedi-Notash G, Jalali-Farahani S, Khalili D, Azizi F. Predisposing factors of long-term responsiveness in a cardio-metabolic cohort: Tehran Lipid and Glucose Study. BMC Med Res Methodol. 2021 08 09; 21(1):161. PMID: 34372764.
    Citations:    Fields:    Translation:Humans
  30. Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Azizi F. Endogenous estrogen exposure and chronic kidney disease; a 15-year prospective cohort study. BMC Endocr Disord. 2021 Aug 04; 21(1):155. PMID: 34348694.
    Citations: 1     Fields:    Translation:Humans
  31. Toreyhi H, Asgari S, Khalili D, Pishgahi M, Azizi F, Hadaegh F. Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study. Sci Rep. 2021 08 03; 11(1):15720. PMID: 34344986.
    Citations:    Fields:    Translation:Humans
  32. Nosratzehi S, Tasdighi E, Hadaegh F, Khalili D, Mahdavi M, Valizadeh M. Contribution of obesity in increasing type 2 diabetes prevalence in Iranian urban and rural adults during recent decade. Prim Care Diabetes. 2021 12; 15(6):1052-1057. PMID: 34353743.
    Citations:    Fields:    Translation:Humans
  33. Koohi F, Ahmadi N, Hadaegh F, Safiee S, Azizi F, Khalili D. Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study. J Transl Med. 2021 07 16; 19(1):309. PMID: 34271961.
    Citations:    Fields:    Translation:Humans
  34. Moazzeni SS, Hizomi Arani R, Deravi N, Hasheminia M, Khalili D, Azizi F, Hadaegh F. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study. Cardiovasc Diabetol. 2021 07 12; 20(1):141. PMID: 34253199.
    Citations: 2     Fields:    Translation:Humans
  35. Ahmadi N, Valizadeh M, Hadaegh F, Mahdavi M, Tasdighi E, Azizi F, Khalili D. Metabolic risk factors among prediabetic individuals and the trajectory toward the diabetes incidence. J Diabetes. 2021 Nov; 13(11):905-914. PMID: 34129291.
    Citations:    Fields:    Translation:Humans
  36. Koohi F, Khalili D, Mansournia MA, Hadaegh F, Soori H. Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies. J Transl Med. 2021 07 03; 19(1):286. PMID: 34217318.
    Citations:    Fields:    Translation:Humans
  37. Khalagi K, Gharibzadeh S, Khalili D, Mansournia MA, Mirab Samiee S, Aghamohamadi S, Mir-Mohammad-Ali Roodaki M, Hashemi SM, Tayeri K, Namdari Tabar H, Azadmanesh K, Tabrizi JS, Mohammad K, Hajipour F, Namaki S, Raeisi A, Ostovar A. Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme. Clin Microbiol Infect. 2021 Nov; 27(11):1666-1671. PMID: 34111585.
    Citations: 9     Fields:    Translation:Humans
  38. Akbarzadeh M, Riahi P, Ramezankhani A, Dehkordi SR, Roudbar MA, Zarkesh M, Guity K, Khalili D, Zahedi AS, Azizi F, Daneshpour MS. Parental Transmission Plays the Major Role in High Aggregation of Type 2 Diabetes in Iranian Families: Tehran Lipid and Glucose Study. Can J Diabetes. 2022 Feb; 46(1):60-68. PMID: 34419346.
    Citations:    Fields:    Translation:Humans
  39. Khalagi K, Gharibzadeh S, Khalili D, Mirab Samiee S, Hashemi SM, Aghamohamadi S, Mir-Mohammad-Ali Roodaki M, Tayeri K, Namdari Tabar H, Azadmanesh K, Tabrizi JS, Mohammad K, Goudarzi S, Hajipour F, Namaki S, Raeisi A, Ostovar A. Nationwide population-based surveys of Iranian COVID-19 Serological Surveillance (ICS) program: The surveys protocol. Med J Islam Repub Iran. 2021; 35:61. PMID: 34277498.
    Citations: 2     
  40. Lotfaliany M, Hadaegh F, Mansournia MA, Azizi F, Oldenburg B, Khalili D. Performance of Stepwise Screening Methods in Identifying Individuals at High Risk of Type 2 Diabetes in an Iranian Population. Int J Health Policy Manag. 2021 May 05. PMID: 34060272.
    Citations:    Fields:    
  41. Ahanchi NS, Hadaegh F, Azizi F, Khalili D. Sex- specific clustering of metabolic syndrome components and incidence of cardiovascular disease: A latent class analysis in a population-based cohort study. J Diabetes Complications. 2021 07; 35(7):107942. PMID: 33965337.
    Citations: 1     Fields:    Translation:Humans
  42. Koohi F, Steyerberg EW, Cheraghi L, Abdshah A, Azizi F, Khalili D. Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS). BMC Public Health. 2021 04 24; 21(1):790. PMID: 33894756.
    Citations:    Fields:    Translation:Humans
  43. Bagheri P, Khalili D, Seif M, Rezaianzadeh A. Dynamic behavior of metabolic syndrome progression: a comprehensive systematic review on recent discoveries. BMC Endocr Disord. 2021 Mar 22; 21(1):54. PMID: 33752643.
    Citations: 3     Fields:    Translation:Humans
  44. Asgari S, Khalili D, Hosseinpanah F, Hadaegh F. Prediction Models for Type 2 Diabetes Risk in the General Population: A Systematic Review of Observational Studies. Int J Endocrinol Metab. 2021 Jul; 19(3):e109206. PMID: 34567135; PMCID: PMC8453657.
    Citations: 1     
  45. Solaymani-Dodaran M, Ghanei M, Bagheri M, Qazvini A, Vahedi E, Hassan Saadat S, Amin Setarehdan S, Ansarifar A, Biganeh H, Mohazzab A, Khalili D, Hosein Ghazale A, Reza Heidari M, Taheri A, Khoramdad M, Mahdi Asadi M, Nazemieh M, Varshochi M, Abbasian S, Bakhtiari A, Mosaed R, Hosseini-Shokouh SJ, Shahrokhi M, Yassin Z, Ali Zohal M, Qaraati M, Rastgoo N, Sami R, Javad Eslami M, Asghari A, Namazi M, Ziaie S, Jafari-Moghaddam R, Kalantari S, Memarian M, Khodadadi J, Hossein Afshari M, Momen-Heravi M, Behzadseresht N, Reza Mobayen A, Mozafari A, Movasaghi F, Haddadzadeh Shoushtari M, Moazen J. Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. Int Immunopharmacol. 2021 Jun; 95:107522. PMID: 33735712.
    Citations: 17     Fields:    Translation:Humans
  46. Ahanchi NS, Tamehri Zadeh SS, Khalili D, Azizi F, Hadaegh F. Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study. J Transl Med. 2021 02 23; 19(1):84. PMID: 33622340.
    Citations: 1     Fields:    Translation:Humans
  47. Mehran L, Azizi F, Mousapour P, Cheraghi L, Yarahmadi S, Amirshekari G, Khalili D. Development of a risk prediction model for early discrimination between permanent and transient congenital hypothyroidism. Endocrine. 2021 08; 73(2):374-383. PMID: 33616836.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  48. Khalili D, Bagheri P, Seif M, Rezaianzadeh A, Morasae EK, Bahramali E, Azizi F. The dynamics of metabolic syndrome development from its isolated components among Iranian adults: findings from 17 years of the Tehran lipid and glucose study (TLGS). J Diabetes Metab Disord. 2021 Jun; 20(1):95-105. PMID: 34178824; PMCID: PMC8212343.
    Citations: 1     
  49. Rahmani F, Asgari S, Khalili D, Habibi Moeini AS, Tohidi M, Azizi F, Hadaegh F. National trends in cardiovascular health metrics among Iranian adults using results of three cross-sectional STEPwise approaches to surveillance surveys. Sci Rep. 2021 01 08; 11(1):58. PMID: 33420115.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  50. Hadaegh F, Asgari S, Moosaie F, Orangi M, Sarvghadi F, Khalili D, Azizi F. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study. J Transl Med. 2021 01 06; 19(1):25. PMID: 33407576.
    Citations:    Fields:    Translation:Humans
  51. Amiri P, Naseri P, Vahedi-Notash G, Jalali-Farahani S, Mehrabi Y, Hamzavi-Zarghani N, Azizi F, Hadaegh F, Khalili D. Trends of low physical activity among Iranian adolescents across urban and rural areas during 2006-2011. Sci Rep. 2020 12 07; 10(1):21318. PMID: 33288806.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  52. Naseri P, Amiri P, Masihay-Akbar H, Jalali-Farahani S, Khalili D, Azizi F. Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study. BMC Public Health. 2020 Nov 04; 20(1):1654. PMID: 33148219.
    Citations: 2     Fields:    Translation:Humans
  53. Saadati H, Baradaran HR, Danaei G, Ostovar A, Hadaegh F, Janani L, Steyerberg EW, Khalili D. Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease. BMC Med Inform Decis Mak. 2020 11 04; 20(1):288. PMID: 33148227.
    Citations:    Fields:    Translation:HumansPHPublic Health
  54. Erfanpoor S, Etemad K, Kazempour S, Hadaegh F, Hasani J, Azizi F, Parizadeh D, Khalili D. Diabetes, Hypertension, and Incidence of Chronic Kidney Disease: Is There any Multiplicative or Additive Interaction? Int J Endocrinol Metab. 2021 Jan; 19(1):e101061. PMID: 33815514; PMCID: PMC8010431.
    Citations: 2     
  55. Koohi F, Khalili D. Knowledge, Attitude, and Practice Regarding Cardiovascular Diseases in Adults Attending Health Care Centers in Tehran, Iran. Int J Endocrinol Metab. 2020 Jul; 18(3):e101612. PMID: 33257905; PMCID: PMC7695352.
    Citations: 1     
  56. Zahedi M, Kazemian E, Ramezani-Tehrani F, Tohidi M, Azizi F, Khalili D, Rahmati M, Amouzegar A. Assessment of the simultaneous effect of hypothyroidism and thyroid autoimmunity with gestational diabetes on the incidence of type 2 diabetes. BMC Endocr Disord. 2020 Oct 01; 20(1):150. PMID: 32998711.
    Citations: 2     Fields:    Translation:Humans
  57. Farahmand M, Khalili D, Ramezani Tehrani F, Amin G, Negarandeh R. Effectiveness of Echium amoenum on premenstrual syndrome: a randomized, double-blind, controlled trial. BMC Complement Med Ther. 2020 Sep 29; 20(1):295. PMID: 32993653.
    Citations: 1     Fields:    Translation:HumansAnimals
  58. Amiri M, Nahidi F, Yarandi RB, Khalili D, Tohidi M, Tehrani FR. Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial. Health Qual Life Outcomes. 2020 Aug 31; 18(1):293. PMID: 32867790; PMCID: PMC7460764.
    Citations: 1     Fields:    Translation:Humans
  59. Lotfaliany M, Mansournia MA, Azizi F, Hadaegh F, Zafari N, Ghanbarian A, Mirmiran P, Oldenburg B, Khalili D. Long-term effectiveness of a lifestyle intervention on the prevention of type 2 diabetes in a middle-income country. Sci Rep. 2020 08 25; 10(1):14173. PMID: 32843718.
    Citations: 2     Fields:    Translation:Humans
  60. Azimi SS, Koohi F, Aghaali M, Nikbakht R, Mahdavi M, Mokhayeri Y, Mohammadi R, Taherpour N, Nakhaeizadeh M, Khalili D, Sharifi H, Hashemi Nazari SS. Estimation of the basic reproduction number (??0) of the COVID-19 epidemic in Iran. Med J Islam Repub Iran. 2020; 34:95. PMID: 33315980.
    Citations: 3     
  61. Saatchi M, Mansournia MA, Khalili D, Daroudi R, Yazdani K. Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS). Risk Manag Healthc Policy. 2020; 13:1015-1028. PMID: 32848484; PMCID: PMC7431169.
    Citations:    
  62. Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, Hadaegh F. Correction To: Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study. Glob Heart. 2020 Jul 29; 15(1):49. PMID: 32923343; PMCID: PMC7413166.
    Citations:    Fields:    
  63. Hosseini-Esfahani F, Koochakpoor G, Tahmasebinejad Z, Khalili D, Mirmiran P, Azizi F. The association of dietary macronutrients composition with the incidence of cardiovascular disease, using iso-energetic substitution models: Tehran lipid and glucose study. Nutr Metab Cardiovasc Dis. 2020 11 27; 30(12):2186-2193. PMID: 32980248.
    Citations:    Fields:    Translation:HumansPHPublic Health
  64. Malekzadeh H, Lotfaliany M, Ostovar A, Hadaegh F, Azizi F, Yoosefi M, Farzadfar F, Khalili D. Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007-2016. Sci Rep. 2020 07 16; 10(1):11724. PMID: 32678170.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  65. Farahmand M, Khalili D, Ramezani Tehrani F, Amin G, Negarandeh R. Could Anise decrease the intensity of premenstrual syndrome symptoms in comparison to placebo? A double-blind randomized clinical trial. J Complement Integr Med. 2020 Jul 08. PMID: 32692701.
    Citations: 2     Fields:    
  66. Asgari S, Moosaie F, Khalili D, Azizi F, Hadaegh F. External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population. J Transl Med. 2020 07 02; 18(1):267. PMID: 32615996.
    Citations: 3     Fields:    Translation:Humans
  67. Asgari S, Lotfaliany M, Fahimfar N, Hadaegh F, Azizi F, Khalili D. The external validity and performance of the no-laboratory American Diabetes Association screening tool for identifying undiagnosed type 2 diabetes among the Iranian population. Prim Care Diabetes. 2020 12; 14(6):672-677. PMID: 32522438.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  68. Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, Hadaegh F. Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study. Glob Heart. 2020 04 08; 15(1):29. PMID: 32489802.
    Citations: 7     Fields:    Translation:Humans
  69. Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Azizi F. Is there any association between age at menarche and anthropometric indices? A 15-year follow-up population-based cohort study. Eur J Pediatr. 2020 Sep; 179(9):1379-1388. PMID: 32146570.
    Citations: 3     Fields:    Translation:Humans
  70. Amiri M, Nahidi F, Bidhendi-Yarandi R, Khalili D, Tohidi M, Ramezani Tehrani F. A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial. Hum Reprod. 2020 01 01; 35(1):175-186. PMID: 31916574.
    Citations: 6     Fields:    Translation:Humans
  71. Lee CMY, Colagiuri S, Woodward M, Gregg EW, Adams R, Azizi F, Gabriel R, Gill TK, Gonzalez C, Hodge A, Jacobs Jr DR, Joseph JJ, Khalili D, Magliano DJ, Mehlig K, Milne R, Mishra G, Mongraw-Chaffin M, Pasco JA, Sakurai M, Schreiner PJ, Selvin E, Shaw JE, Wittert G, Yatsuya H, Huxley RR. Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes. BMJ Open Diabetes Res Care. 2019; 7(1):e000794. PMID: 31908797; PMCID: PMC6936411.
    Citations: 7     Translation:Humans
  72. Pahlavanzade B, Zayeri F, Baghfalaki T, Mozafari O, Khalili D, Azizi F, Abadi A. Association of lipid markers with coronary heart disease and stroke mortality: A 15-year follow-up study. Iran J Basic Med Sci. 2019 Nov; 22(11):1325-1330. PMID: 32128098; PMCID: PMC7038418.
    Citations: 1     
  73. Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhani A, Ahmadi Pishkuhi M, Rostami Gooran S, Fotouhi A. Relationship between lifestyle pattern and blood pressure - Iranian national survey. Sci Rep. 2019 10 23; 9(1):15194. PMID: 31645585.
    Citations: 1     Fields:    Translation:Humans
  74. Pahlavanzade B, Zayeri F, Baghfalaki T, Hadaeg F, Khalili D, Shoaib Hamrah M, Paul E, Azizi F, Abadi A. Serum Lipids and Cardiovascular Disease Mortality in Iranian Population: Joint Modeling of Longitudinal and Survival Data in Tehran Lipid and Glucose Study (TLGS) Cohort. Galen Med J. 2019; 8:e1516. PMID: 34466521; PMCID: PMC8343986.
    Citations:    
  75. Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, Mehrabi Y, Takyar M. Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial. Thyroid. 2019 09; 29(9):1192-1200. PMID: 31310160.
    Citations: 17     Fields:    Translation:Humans
  76. Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfaliany M, Takyar F, Khalili D. Metabolic health in the Middle East and north Africa. Lancet Diabetes Endocrinol. 2019 11; 7(11):866-879. PMID: 31422063.
    Citations: 34     Fields:    Translation:Humans
  77. Mehran L, Yarahmadi S, Khalili D, Hedayati M, Amouzegar A, Mousapour P, Ajang N, Azizi F. Audit of the Congenital Hypothyroidism Screening Program in 15 Provinces of Iran. Arch Iran Med. 2019 06 01; 22(6):310-317. PMID: 31356097.
    Citations:    Fields:    Translation:HumansPHPublic Health
  78. Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, Khalili D, Vakili AZ, Azizi F. Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto's Thyroiditis? A Double Blind, Randomized Clinical Trial. Horm Metab Res. 2019 May; 51(5):296-301. PMID: 31071734.
    Citations: 21     Fields:    Translation:Humans
  79. Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, Ahmadvand A, Arabi M, Ardalan A, Arhami M, Azizi MH, Bahadori M, Baumgartner J, Beheshtian A, Djalalinia S, Doshmangir L, Haghdoost AA, Haghshenas R, Hosseinpoor AR, Islami F, Kamangar F, Khalili D, Madani K, Masoumi-Asl H, Mazyaki A, Mirchi A, Moradi E, Nayernouri T, Niemeier D, Omidvari AH, Peykari N, Pishgar F, Qorbani M, Rahimi K, Rahimi-Movaghar A, Tehrani FR, Rezaei N, Shahraz S, Takian A, Tootee A, Ezzati M, Jamshidi HR, Larijani B, Majdzadeh R, Malekzadeh R. Iran in transition. Lancet. 2019 05 11; 393(10184):1984-2005. PMID: 31043324.
    Citations: 37     Fields:    Translation:HumansPHPublic Health
  80. Asgari S, Khaloo P, Khalili D, Azizi F, Hadaegh F. Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012-2015. Sci Rep. 2019 04 23; 9(1):6382. PMID: 31011156.
    Citations: 8     Fields:    Translation:Humans
  81. Amiri P, Vahedi-Notash G, Naseri P, Khalili D, Hashemi Nazari SS, Mehrabi Y, Mahdavi Hazaveh AR, Azizi F, Hadaegh F. Correction to: National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011). Biol Sex Differ. 2019 04 15; 10(1):18. PMID: 30987682.
    Citations:    Fields:    
  82. Amiri P, Vahedi-Notash G, Naseri P, Khalili D, Hashemi Nazari SS, Mehrabi Y, Mahdavi Hazaveh AR, Azizi F, Hadaegh F. National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011). Biol Sex Differ. 2019 03 29; 10(1):15. PMID: 30922399; PMCID: PMC6439987.
    Citations: 5     Fields:    Translation:Humans
  83. Lotfaliany M, Hadaegh F, Asgari S, Mansournia MA, Azizi F, Oldenburg B, Khalili D. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population. Arch Iran Med. 2019 03 01; 22(3):116-124. PMID: 31029067.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  84. Khalili D, Asgari S, Lotfaliany M, Zafari N, Hadaegh F, Momenan AA, Nowroozpoor A, Hosseini-Esfahani F, Mirmiran P, Amiri P, Azizi F. Long-Term Effectiveness of a Lifestyle Intervention: A Pragmatic Community Trial to Prevent Metabolic Syndrome. Am J Prev Med. 2019 03; 56(3):437-446. PMID: 30777162.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  85. Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Bahri Khomami M, Azizi F. Association between duration of endogenous estrogen exposure and cardiovascular outcomes: A population - based cohort study. Life Sci. 2019 Mar 15; 221:335-340. PMID: 30763578.
    Citations: 3     Fields:    Translation:Humans
  86. Ahanchi NS, Hadaegh F, Alipour A, Ghanbarian A, Azizi F, Khalili D. Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study. Sci Rep. 2019 02 07; 9(1):1572. PMID: 30733469.
    Citations: 2     Fields:    Translation:Humans
  87. Khajavi A, Khalili D, Azizi F, Hadaegh F. Impact of temperature and air pollution on cardiovascular disease and death in Iran: A 15-year follow-up of Tehran Lipid and Glucose Study. Sci Total Environ. 2019 Apr 15; 661:243-250. PMID: 30677672.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  88. Farrokhian A, Tohidi M, Ahanchi NS, Khalili D, Niroomand M, Mahboubi A, Derakhshi A, Abbasinazari M, Hadaegh F. Effect of Bedtime Melatonin Administration in Patients with Type 2 Diabetes: A Triple-Blind, Placebo-Controlled, Randomized Trial. Iran J Pharm Res. 2019; 18(Suppl1):258-268. PMID: 32802105; PMCID: PMC7393042.
    Citations: 2     
  89. Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, Khalili D, Cheraghi L, Kazemijaliseh H, Azizi F. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril. 2018 12; 110(7):1377-1386. PMID: 30503137.
    Citations: 14     Fields:    Translation:Humans
  90. Ramezankhani A, Harati H, Bozorgmanesh M, Tohidi M, Khalili D, Azizi F, Hadaegh F. Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018 Oct; 16(4 Suppl):e84784. PMID: 30584445; PMCID: PMC6289292.
    Citations: 10     
  91. Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A, Eskandari F, Sheikholeslami F, Hadaegh F. Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018 Oct; 16(4 Suppl):e84748. PMID: 30584434; PMCID: PMC6289305.
    Citations: 13     
  92. Lotfaliany M, Akbarpour S, Zafari N, Mansournia MA, Asgari S, Azizi F, Hadaegh F, Khalili D. World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study. Int J Endocrinol Metab. 2018 Jul; 16(3):e59946. PMID: 30464769; PMCID: PMC6208042.
    Citations: 4     
  93. Fahimfar N, Khalili D, Sepanlou SG, Malekzadeh R, Azizi F, Mansournia MA, Roohafza H, Emamian MH, Hadaegh F, Poustchi H, Mansourian M, Hashemi H, Sharafkhah M, Pourshams A, Farzadfar F, Steyerberg EW, Fotouhi A. Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium. BMJ Open. 2018 07 05; 8(7):e020303. PMID: 29980541.
    Citations: 7     Fields:    Translation:Humans
  94. Zafari N, Lotfaliany M, Mansournia MA, Khalili D, Azizi F, Hadaegh F. Optimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study. BMC Public Health. 2018 06 05; 18(1):691. PMID: 29866083.
    Citations: 4     Fields:    Translation:Humans
  95. Bakhtiyari M, Schmidt N, Hadaegh F, Khalili D, Mansournia N, Asgari S, Mansournia MA. Direct and indirect effects of central and general adiposity on cardiovascular diseases: The Tehran Lipid and Glucose Study. Eur J Prev Cardiol. 2018 07; 25(11):1170-1181. PMID: 29856228.
    Citations: 3     Fields:    Translation:Humans
  96. Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhani A, Fotouhi A. Healthy lifestyle behaviors and control of hypertension among adult hypertensive patients. Sci Rep. 2018 05 31; 8(1):8508. PMID: 29855520.
    Citations: 12     Fields:    Translation:Humans
  97. Rabani S, Sardarinia M, Akbarpour S, Azizi F, Khalili D, Hadaegh F. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study. PLoS One. 2018; 13(5):e0195543. PMID: 29768511.
    Citations: 2     Fields:    Translation:Humans
  98. Amiri P, Jalali-Farahani S, Akbar HM, Cheraghi L, Khalili D, Momenan A, Mirmiran P, Ghanbarian A, Hedayati M, Hosseini-Esfahani F, Azizi F. The Effects of a Community-Based Lifestyle Intervention on Metabolic Syndrome and Its Components in Adolescents: Findings of a Decade Follow-Up. Metab Syndr Relat Disord. 2018 06; 16(5):215-223. PMID: 29648906.
    Citations: 6     Fields:    Translation:Humans
  99. Asgari S, Abdi H, Hezaveh AM, Moghisi A, Etemad K, Beni HR, Khalili D. The Burden of Statin Therapy based on ACC/AHA and NCEP ATP-III Guidelines: An Iranian Survey of Non-Communicable Diseases Risk Factors. Sci Rep. 2018 03 21; 8(1):4928. PMID: 29563602.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  100. Mehran L, Khalili D, Yarahmadi S, Delshad H, Mehrabi Y, Amouzegar A, Ajang N, Azizi F. Evaluation of the congenital hypothyroidism screening programme in Iran: a 3-year retrospective cohort study. Arch Dis Child Fetal Neonatal Ed. 2019 Mar; 104(2):F176-F181. PMID: 29540462.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  101. Kabootari M, Asgari S, Mansournia MA, Khalili D, Valizadeh M, Azizi F, Hadaegh F. Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study. J Am Heart Assoc. 2018 02 10; 7(4). PMID: 29440011.
    Citations: 4     Fields:    Translation:Humans
  102. Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhanim A, Fotouhi A. Lifestyle patterns in the Iranian population: Self- organizing map application. Caspian J Intern Med. 2018; 9(3):268-275. PMID: 30197772; PMCID: PMC6121339.
    Citations: 3     
  103. Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, Azizi F. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril. 2017 12; 108(6):1078-1084. PMID: 29202960.
    Citations: 14     Fields:    Translation:Humans
  104. Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, Azizi F. Predictors of early adulthood hypertension during adolescence: a population-based cohort study. BMC Public Health. 2017 11 28; 17(1):915. PMID: 29183297.
    Citations: 17     Fields:    Translation:Humans
  105. Gilani N, Kazemnejad A, Zayeri F, Hadaegh F, Azizi F, Khalili D. Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event. Iran J Public Health. 2017 Nov; 46(11):1546-1554. PMID: 29167774; PMCID: PMC5696695.
    Citations: 4     
  106. Mehran L, Yarahmadi S, Khalili D, Nazeri P, Delshad H, Abdollahi Z, Azhang N, Azizi F. The Impact of Iodine Status on the Recall Rate of the Screening Program for Congenital Hypothyroidism: Findings from Two National Studies in Iran. Nutrients. 2017 Oct 30; 9(11). PMID: 29084139.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  107. Amiri M, Nahidi F, Khalili D, Bidhendi-Yarandi R, Ramezani Tehrani F. Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017 Sep 29; 6(9):e191. PMID: 28963092; PMCID: PMC5640820.
    Citations:    
  108. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data. Arch Iran Med. 2017 Sep; 20(9):558-563. PMID: 29048917.
    Citations: 5     Fields:    Translation:Humans
  109. Farahmand M, Ramezani Tehrani F, Khalili D, Amin G, Negarandeh R. Factors associated with the severity of premenstrual syndrome among Iranian college students. J Obstet Gynaecol Res. 2017 Nov; 43(11):1726-1731. PMID: 28737241.
    Citations: 3     Fields:    Translation:Humans
  110. Taravatmanesh S, Khalili D, Khodakarim S, Asgari S, Hadaegh F, Azizi F, Sabour S. Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study. J Tehran Heart Cent. 2017 Jul; 12(3):107-113. PMID: 29062377; PMCID: PMC5643867.
    Citations: 3     
  111. Barzin M, Motamedi MAK, Serahati S, Khalaj A, Arian P, Valizadeh M, Khalili D, Azizi F, Hosseinpanah F. Comparison of the Effect of Gastric Bypass and Sleeve Gastrectomy on Metabolic Syndrome and its Components in a Cohort: Tehran Obesity Treatment Study (TOTS). Obes Surg. 2017 07; 27(7):1697-1704. PMID: 28054293.
    Citations: 4     Fields:    Translation:Humans
  112. Mehran L, Khalili D, Yarahmadi S, Amouzegar A, Mojarrad M, Ajang N, Azizi F. Worldwide Recall Rate in Newborn Screening Programs for Congenital Hypothyroidism. Int J Endocrinol Metab. 2017 Jul; 15(3):e55451. PMID: 29201074; PMCID: PMC5702453.
    Citations: 11     
  113. Ramezankhani A, Bagherzadeh-Khiabani F, Khalili D, Azizi F, Hadaegh F. A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study. Sci Rep. 2017 06 12; 7(1):3237. PMID: 28607472.
    Citations: 4     Fields:    Translation:Humans
  114. Mansournia MA, Holakouie-Naieni K, Fahimfar N, Almasi-Hashiani A, Cheraghi Z, Ayubi E, Hadaegh F, Eskandari F, Azizi F, Khalili D. Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2017 Apr; 15(2):e42713. PMID: 28848610; PMCID: PMC5556326.
    Citations:    
  115. Daneshpour MS, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, Ebrahimi A, Hajsheikholeslami F, Mirmiran P, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Amouzegar A, Amiri P, Azizi F. Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS). JMIR Res Protoc. 2017 Feb 23; 6(2):e28. PMID: 28232301; PMCID: PMC5344981.
    Citations: 26     
  116. Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health. 2017 01 31; 17(1):133. PMID: 28137245.
    Citations: 17     Fields:    Translation:HumansAnimals
  117. Ueda P, Woodward M, Lu Y, Hajifathalian K, Al-Wotayan R, Aguilar-Salinas CA, Ahmadvand A, Azizi F, Bentham J, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ferguson TS, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano DJ, Margozzini P, Msyamboza KP, Mutungi G, Oh K, Oum S, Rodríguez-Artalejo F, Rojas-Martinez R, Valdivia G, Wilks R, Shaw JE, Stevens GA, Tolstrup JS, Zhou B, Salomon JA, Ezzati M, Danaei G. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. Lancet Diabetes Endocrinol. 2017 03; 5(3):196-213. PMID: 28126460; PMCID: PMC5354360.
    Citations: 40     Fields:    Translation:Humans
  118. Eslami A, Mozaffary A, Derakhshan A, Azizi F, Khalili D, Hadaegh F. Sex-specific incidence rates and risk factors of premature cardiovascular disease. A long term follow up of the Tehran Lipid and Glucose Study. Int J Cardiol. 2017 Jan 15; 227:826-832. PMID: 27829526.
    Citations: 16     Fields:    Translation:Humans
  119. Panahi MH, Hadaegh F, Yavari P, Kazempour-Ardebili S, Mehrabi Y, Azizi F, Khalili D. A Challenging Interaction of Chronic Kidney Disease With Other Metabolic Disorders: Paradoxes in Cardiometabolic Risk Factors. Iran J Kidney Dis. 2016 Sep; 10(5):274-281. PMID: 27721225.
    Citations: 1     Fields:    Translation:Humans
  120. Cheraghi Z, Mirmiran P, Mansournia MA, Moslehi N, Khalili D, Nedjat S. The association between nutritional exposures and metabolic syndrome in the Tehran Lipid and Glucose Study (TLGS): a cohort study. Public Health. 2016 Nov; 140:163-171. PMID: 27498945.
    Citations: 7     Fields:    Translation:Humans
  121. Ghasemzadeh Z, Abdi H, Asgari S, Tohidi M, Khalili D, Valizadeh M, Moeini S, Eidkhani V, Azizi F, Hadaegh F. Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population. Nutr Metab (Lond). 2016; 13:43. PMID: 27346994; PMCID: PMC4919865.
    Citations: 9     
  122. Helgadottir A, Gretarsdottir S, Thorleifsson G, Hjartarson E, Sigurdsson A, Magnusdottir A, Jonasdottir A, Kristjansson H, Sulem P, Oddsson A, Sveinbjornsson G, Steinthorsdottir V, Rafnar T, Masson G, Jonsdottir I, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Daneshpour MS, Khalili D, Azizi F, Swinkels DW, Kiemeney L, Quyyumi AA, Levey AI, Patel RS, Hayek SS, Gudmundsdottir IJ, Thorgeirsson G, Thorsteinsdottir U, Gudbjartsson DF, Holm H, Stefansson K. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat Genet. 2016 06; 48(6):634-9. PMID: 27135400; PMCID: PMC9136713.
    Citations: 87     Fields:    Translation:Humans
  123. Asgari S, Barzin M, Hosseinpanah F, Hadaegh F, Azizi F, Khalili D. Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2016 Apr; 14(2):e37018. PMID: 27761144; PMCID: PMC5055747.
    Citations: 2     
  124. Afsharian S, Akbarpour S, Abdi H, Sheikholeslami F, Moeini AS, Khalili D, Momenan AA, Azizi F, Hadaegh F. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes?-?a 10-year follow-up: Tehran Lipid and Glucose Study. Diabetes Metab Res Rev. 2016 09; 32(6):596-606. PMID: 26787367.
    Citations: 15     Fields:    Translation:Humans
  125. Bagherzadeh-Khiabani F, Steyerberg EW, Khalili D. The authors' reply to letter to the editor re: Bagherzadeh-Khiabani et al., J Clin Epi, 2015. J Clin Epidemiol. 2016 07; 75:131-2. PMID: 26939930.
    Citations:    Fields:    
  126. Hadaegh F, Derakhshan A, Mozaffary A, Hasheminia M, Khalili D, Azizi F. Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study. PLoS One. 2016; 11(3):e0149780. PMID: 26930192; PMCID: PMC4773225.
    Citations: 6     Fields:    Translation:Humans
  127. Barzin M, Hosseinpanah F, Motamedi MA, Shapoori P, Arian P, Daneshpour MA, Asghari G, Teymoornejad A, Eslamifar A, Khalili D, Jodeiri B, Alamdari S, Azizi F, Khalaj A. Bariatric Surgery for Morbid Obesity: Tehran Obesity Treatment Study (TOTS) Rationale and Study Design. JMIR Res Protoc. 2016 Jan 20; 5(1):e8. PMID: 26792554; PMCID: PMC4740496.
    Citations: 19     
  128. Asgari S, Khalili D, Mehrabi Y, Kazempour-Ardebili S, Azizi F, Hadaegh F. Incidence and risk factors of isolated systolic and diastolic hypertension: a 10 year follow-up of the Tehran Lipids and Glucose Study. Blood Press. 2016 Jun; 25(3):177-83. PMID: 26643588.
    Citations: 16     Fields:    Translation:Humans
  129. Bagherzadeh-Khiabani F, Ramezankhani A, Azizi F, Hadaegh F, Steyerberg EW, Khalili D. A tutorial on variable selection for clinical prediction models: feature selection methods in data mining could improve the results. J Clin Epidemiol. 2016 Mar; 71:76-85. PMID: 26475568.
    Citations: 28     Fields:    Translation:Humans
  130. Hadaegh F, Hasheminia M, Abdi H, Khalili D, Bozorgmanesh M, Arshi B, Azizi F. Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population. PLoS One. 2015; 10(10):e0139412. PMID: 26439847.
    Citations: 10     Fields:    Translation:Humans
  131. Masudi S, Yavari P, Mehrabi Y, Azizi F, Khalili D, Hadaegh F. Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2015 Oct; 13(4):e27528. PMID: 26587030; PMCID: PMC4648128.
    Citations: 2     
  132. Khalili M, Vasei M, Khalili D, Alimoghaddam K, Sadeghizadeh M, Mowla SJ. Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma. J Gastrointest Cancer. 2015 Sep; 46(3):251-8. PMID: 25904219.
    Citations: 12     Fields:    Translation:HumansCells
  133. Hashemi Nazari SS, Shakiba M, Khalili D, Hadaegh F, Tohidi M, Azizi F. High-density lipoprotein cholesterol, a protective or a risk factor for developing coronary heart disease? Tehran Lipid and Glucose Study. J Clin Lipidol. 2015 Jul-Aug; 9(4):553-8. PMID: 26228673.
    Citations: 5     Fields:    Translation:Humans
  134. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Azizi F. The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study. Glob J Health Sci. 2015 Apr 19; 7(6):226-32. PMID: 26153187.
    Citations: 30     Fields:    Translation:Humans
  135. Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, Azizi F, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano D, Msyamboza KP, Oh K, Rodríguez-Artalejo F, Rojas-Martinez R, Shaw JE, Stevens GA, Tolstrup J, Zhou B, Salomon JA, Ezzati M, Danaei G. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015 May; 3(5):339-55. PMID: 25819778.
    Citations: 83     Fields:    Translation:Humans
  136. Khalili D, Asgari S, Hadaegh F, Steyerberg EW, Rahimi K, Fahimfar N, Azizi F. A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: A population-based study. Int J Cardiol. 2015 Apr 01; 184:587-594. PMID: 25769004.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  137. Ayubi E, Khalili D, Delpisheh A, Hadaegh F, Azizi F. Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population. J Diabetes. 2015 Nov; 7(6):830-8. PMID: 25492310.
    Citations: 10     Fields:    Translation:Humans
  138. Azimi SS, Khalili D, Hadaegh F, Yavari P, Mehrabi Y, Azizi F. Calculating population attributable fraction for cardiovascular risk factors using different methods in a population based cohort study. J Res Health Sci. 2015; 15(1):22-7. PMID: 25821021.
    Citations: 7     Fields:    Translation:Humans
  139. Masudi S, Yavari P, Mehrabi Y, Khalili D, Azizi F. Regression dilution bias in blood pressure and body mass index in a longitudinal population-based cohort study. J Res Health Sci. 2015; 15(2):77-82. PMID: 26175288.
    Citations: 2     Fields:    Translation:Humans
  140. Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, Mansournia MA, Azizi F, Hadaegh F. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study. PLoS One. 2014; 9(12):e112639. PMID: 25461381.
    Citations: 21     Fields:    Translation:Humans
  141. Ramezankhani A, Pournik O, Shahrabi J, Azizi F, Hadaegh F, Khalili D. The Impact of Oversampling with SMOTE on the Performance of 3 Classifiers in Prediction of Type 2 Diabetes. Med Decis Making. 2016 01; 36(1):137-44. PMID: 25449060.
    Citations: 19     Fields:    Translation:Humans
  142. Khalili D, Sheikholeslami FH, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One. 2014; 9(8):e105804. PMID: 25162590.
    Citations: 33     Fields:    Translation:Humans
  143. Ramezankhani A, Pournik O, Shahrabi J, Khalili D, Azizi F, Hadaegh F. Applying decision tree for identification of a low risk population for type 2 diabetes. Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2014 Sep; 105(3):391-8. PMID: 25085758.
    Citations: 17     Fields:    Translation:Humans
  144. Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS One. 2014; 9(7):e102563. PMID: 25029368.
    Citations: 39     Fields:    Translation:Humans
  145. Kabir A, Khalili D. Built-in bias in HCV clearance in acute HCV infection. J Hepatol. 2014 Feb; 60(2):461. PMID: 24161407.
    Citations:    Fields:    Translation:Humans
  146. Khalili D, Hadaegh F, Steyerberg EW. The authors reply. Am J Epidemiol. 2013 Apr 15; 177(8):865-6. PMID: 23705141.
    Citations:    Fields:    Translation:Humans
  147. Jahangiri Noudeh Y, Hadaegh F, Vatankhah N, Momenan AA, Saadat N, Khalili D, Azizi F. Wrist circumference as a novel predictor of diabetes and prediabetes: results of cross-sectional and 8.8-year follow-up studies. J Clin Endocrinol Metab. 2013 Feb; 98(2):777-84. PMID: 23341488.
    Citations: 26     Fields:    Translation:Humans
  148. Hadaegh F, Jahangiri Noudeh Y, Tohidi M, Vatankhah N, Khalili D, Mohebi R, Azizi F. Change in general and central adiposity measures in prediction of incident dysglycemia; Tehran Lipid and Glucose Study. Prev Med. 2012 Dec; 55(6):608-12. PMID: 23046898.
    Citations: 3     Fields:    Translation:Humans
  149. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012 Oct 02; 12:117. PMID: 23031547.
    Citations: 18     Fields:    Translation:Humans
  150. Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, Nasiri AA, Azizi F, Hadaegh F. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One. 2012; 7(9):e45304. PMID: 23028919.
    Citations: 44     Fields:    Translation:Humans
  151. Hatami M, Tohidi M, Mohebi R, Khalili D, Azizi F, Hadaegh F. Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population. Lipids Health Dis. 2012 Aug 31; 11:107. PMID: 22937812.
    Citations: 3     Fields:    Translation:Humans
  152. Khalili D, Hadaegh F, Soori H, Steyerberg EW, Bozorgmanesh M, Azizi F. Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study. Am J Epidemiol. 2012 Aug 01; 176(3):177-86. PMID: 22814370.
    Citations: 34     Fields:    Translation:Humans
  153. Khalili D, Hadaegh F, Fahimfar N, Shafiee G, Sheikholeslami F, Ghanbarian A, Azizi F. Does an electrocardiogram add predictive value to the rose angina questionnaire for future coronary heart disease? 10-year follow-up in a Middle East population. J Epidemiol Community Health. 2012 Dec; 66(12):1104-9. PMID: 22544919.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  154. Khalili D, Mosavi-Jarrahi A, Eskandari F, Mousavi-Jarrahi Y, Hadaegh F, Mohagheghi M, Azizi F. Evaluation of cause of deaths' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One. 2012; 7(2):e31427. PMID: 22355365.
    Citations: 8     Fields:    Translation:Humans
  155. Samadi S, Bozorgmanesh M, Khalili D, Momenan A, Sheikholeslami F, Azizi F, Hadaegh F. Hypertriglyceridemic waist: the point of divergence for prediction of CVD vs. mortality: Tehran Lipid and Glucose Study. Int J Cardiol. 2013 May 10; 165(2):260-5. PMID: 21924777.
    Citations: 5     Fields:    Translation:Humans
  156. Hadaegh F, Bozorgmanesh M, Safarkhani M, Khalili D, Azizi F. "Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome?". BMC Public Health. 2011 May 25; 11:383. PMID: 21609497.
    Citations: 10     Fields:    Translation:Humans
  157. Solaymani-Dodaran M, Khalili D, Hosseini H, Najafi L, Kamali K, Ranjbar P, Tavakoli H, Ostovar A. Iranian Registry of Clinical Trials two years on and the timing of registrations. J Evid Based Med. 2011; 4(3):168-71. PMID: 23672721.
    Citations: 3     Fields:    Translation:Humans
  158. Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population. Cardiovasc Diabetol. 2010 Dec 04; 9:84. PMID: 21129219; PMCID: PMC3016329.
    Citations: 23     Fields:    Translation:Humans
  159. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Zabetian A, Mehrabi Y, Kelishadi R, Aghajani H. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010 Sep; 13(5):426-8. PMID: 20804311.
    Citations: 82     Fields:    Translation:Humans
  160. Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Mehrabi Y, Kelishadi R, Hadaegh F. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010 May; 13(3):243-4. PMID: 20433230.
    Citations: 72     Fields:    Translation:Humans
  161. Solaymani-Dodaran M, Ostovar A, Khalili D, Vasei M. Iranian Registry of Clinical Trials: path and challenges from conception to a World Health Organization primary register. J Evid Based Med. 2009 Feb; 2(1):32-5. PMID: 21348980.
    Citations: 6     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Khalili's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (291)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.